Revance Therapeutics Cash from Operations (TTM) Analysis

Revance Therapeutics Inc (RVNC)

3.79 +0.18 (+4.99%) USD | NASDAQ | May 01, 16:00

3.79 0.00 (0.00%) After-Hours: 17:37

Cash from Operations (TTM) Chart

Historical Cash from Operations (TTM) Data

View and export this data back to 2013. Upgrade now.

Date	Value
December 31, 2023	-216.58M
September 30, 2023	-204.03M
June 30, 2023	-210.94M
March 31, 2023	-201.78M
December 31, 2022	-193.55M
September 30, 2022	-207.98M
June 30, 2022	-203.27M
March 31, 2022	-208.05M
December 31, 2021	-221.54M
September 30, 2021	-239.24M
June 30, 2021	-241.76M
March 31, 2021	-209.97M
December 31, 2020	-178.50M
September 30, 2020	-149.70M
June 30, 2020	-125.96M
March 31, 2020	-138.04M
December 31, 2019	-106.16M
September 30, 2019	-103.79M
June 30, 2019	-97.25M
March 31, 2019	-104.52M
December 31, 2018	-104.25M

Date	Value
September 30, 2018	-101.50M
June 30, 2018	-97.56M
March 31, 2018	-85.29M
December 31, 2017	-95.34M
September 30, 2017	-80.41M
June 30, 2017	-73.30M
March 31, 2017	-65.34M
December 31, 2016	-59.83M
September 30, 2016	-62.81M
June 30, 2016	-62.17M
March 31, 2016	-58.32M
December 31, 2015	-55.67M
September 30, 2015	-48.34M
June 30, 2015	-47.32M
March 31, 2015	-46.99M
December 31, 2014	-55.07M
September 30, 2014	-59.93M
June 30, 2014	-53.71M
March 31, 2014	-62.28M
December 31, 2013	-47.76M

Cash From Operations Definition

Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.

Read full definition.

Cash from Operations (TTM) Range, Past 5 Years

-241.76M

Minimum

Jun 2021

-97.25M

Maximum

Jun 2019

-182.00M

Average

-203.27M

Median

Jun 2022

Cash from Operations (TTM) Benchmarks